Laurie H. Glimcher, MD is President and CEO of Dana-Farber Cancer Institute, Director of the Dana-Farber/Harvard Cancer Center and Professor of Medicine at HMS. She is a Member of the NAS, the NAM and Fellow of the AAA&S. She serves on the Board of Directors of GSK plc and Analog Devices, Inc. Dr. Glimcher’s research identified key transcriptional regulators of protective immunity and the origin of pathophysiologic immune responses underlying autoimmune, infectious and malignant diseases.
Current edition
Eventi passati del relatore
Log in
Non sei ancora iscritto? Bastano pochi passaggi per effettuare una nuova registrazione. REGISTRATI ORA